Cancer Diagnostics Market In-depth Insights, Revenue Details, Regional Analysis by 2028 | Qiagen N.V., Siemens Healthcare GmbH, Thermo Fisher Scientific Inc.

The cancer diagnostics market was valued at $168,600.04 million in 2020, and is projected to reach $280,590.21 million by 2028, registering a CAGR of 6.9% from 2021 to 2028.

Cancer diagnostics is the process of detecting biomarkers, proteins, and other indicators that contribute to the detection of a cancerous tumor. Effective diagnostic testing is used to confirm or rule out the presence of infection, monitor disease severity, and plan & evaluate clinical outcomes. Diagnostic procedures for cancer may include imaging, laboratory tests (including tests for tumor markers), endoscopic examination, tumor biopsy, surgery, or genetic testing.

Buy Full Study with Pre and Post Covid-19 Impact Analysis at: https://reportocean.com/industry-verticals/sample-request?report_id=AMR1800

The major factor that contributes to the growth of the cancer diagnostics market includes surge in government initiatives and other private organizations to spread awareness regarding early diagnosis and prevention of cancer, which is anticipated to boost the growth of the market in the coming years. Furthermore, the growth in the number of diagnostics laboratories in developed countries is expected to drive the market growth in the next few years. Increase in incidences and prevalence of various types of cancer, such as breast cancer and lung cancer, are expected to drive the growth of the market.

However, the huge cost associated with diagnostic imaging system and the development of different diagnostic approaches for various cancer mutations may hinder the growth of the market. Conversely, an increase in emphasis over health & safety regulations and surge in popularity of yoga and other health-related practices will act as a growth opportunity during the forecast period.
The cancer diagnostics market is segmented on the basis of basis of product, application, and end use to provide a detailed assessment of the market. By product, the market is bifurcated into consumables and instruments.

Further, consumables are divided into antibodies, kits & reagents, probes, and other consumables. Instruments include pathology-based instruments, imaging instruments, and biopsy instruments. On the basis of application, the market is fragmented into breast cancer, lung cancer, blood cancer, colorectal cancer, skin cancer, ovarian cancer, prostate cancer, kidney cancer, liver cancer, pancreatic cancer, cervical cancer, and others. Based on end use, the market is classified into hospitals & clinics, diagnostic laboratories, diagnostic imaging centers, and research institutes. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Get our sample copy of the report: https://reportocean.com/industry-verticals/ask-for-discount?report_id=AMR1800

KEY BENEFITS FOR STAKEHOLDERS
- The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
- It offers a quantitative analysis from 2020 to 2028, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
- A comprehensive analysis of factors that drive and restrain the growth of the market is provided.
- The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the market.

KEY MARKET SEGMENTS

By Product
- Consumables
o Antibodies
o Kits & Reagents
o Probes
o Other consumables
- Instruments
o Pathology-based Instruments
o Imaging Instruments
o Biopsy Instruments

By Application
- Breast Cancer
- Colorectal Cancer
- Cervical Cancer
- Lung Cancer
- Prostate Cancer
- Skin Cancer
- Blood Cancer
- Kidney Cancer
- Liver Cancer
- Pancreatic Cancer
- Ovarian Cancer
- Others

By End Use
- Hospitals & Clinics
- Diagnostic Laboratories
- Diagnostic Imaging Centers
- Research Institutes

LIST OF KEY PLAYERS PROFILED IN THE REPORT
- Abbott Laboratories
- Becton, Dickinson and Company
- Bio-Rad Laboratories, Inc.
- Roche Holdings AG (F. Hoffmann-La Roche Ltd.)
- Danaher Corporation (GE Healthcare)
- Hologic, Inc.
- Koninklijke Philips N.V. (Philips Healthcare)
- Qiagen N.V.
- Siemens Healthcare GmbH
- Thermo Fisher Scientific Inc.

Get 20% Off On Various License Types When Buy Now At: https://reportocean.com/industry-verticals/sample-request?report_id=AMR1800

Get in Touch with Us:
Report Ocean:
Email: sales@reportocean.com
Address: 500 N Michigan Ave, Suite 600, Chicago, Illinois 60611 - UNITED STATES
Tel: +1 888 212 3539 (US - TOLL FREE)
Website: https://www.reportocean.com/

About Report Ocean:
We are the best market research reports provider in the industry. Report Ocean believes in providing quality reports to clients to meet the top line and bottom line goals which will boost your market share in today's competitive environment. Report Ocean is a 'one-stop solution' for individuals, organizations, and industries that are looking for innovative market research reports.

This release was published on openPR.